Concepedia

Daphne Williams

DW

11

Publications

342

Citations

11

H-Index

2004

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

Research Triangle Park Foundation

Bristol-Myers Squibb (United States)

GlaxoSmithKline (Netherlands)

GlaxoSmithKline (United Kingdom)

Daphne Williams is an author at GlaxoSmithKline (United States) specializing in pharmacotherapy, pharmacokinetics, and medicine.

Top concepts

Publications per year

2004–2016

11

Publications

11

Population Pharmacokinetics of Eltrombopag in Healthy Subjects and Patients With Chronic Idiopathic Thrombocytopenic Purpura

Ekaterina Gibiansky, Jianping Zhang, Daphne Williams et al. · The Journal of Clinical Pharmacology · 2010 · 83 citations

, , +15

Randomized phase I pharmacokinetic study of ipilimumab with or without one of two different chemotherapy regimens in patients with untreated advanced melanoma.

Jeffrey S. Weber, Omid Hamid, Asim Amin et al. · PubMed Central · 2013 · 65 citations · Full text

A Phase I Study of Cantuzumab Mertansine Administered as a Single Intravenous Infusion Once Weekly in Patients with Advanced Solid Tumors

Paul R. Helft, Richard L. Schilsky, Frank Hoke et al. · Clinical Cancer Research · 2004 · 51 citations

Metabolism, Excretion, and Pharmacokinetics of Oral Brivanib in Patients with Advanced or Metastatic Solid Tumors

Tarek Mekhail, Eric Masson, Bruce S. Fischer et al. · Drug Metabolism and Disposition · 2010 · 25 citations · Full text

An Oral, Non-Petide, Small Molecule Thrombopoietin Receptor Agonist Increases Platelet Counts in Healthy Subjects.

J.M. Jenkins, Richard Nicholl, Daphne Williams et al. · Blood · 2004 · 23 citations

Rows per page

1–5 of 11